ADAM17 and cancer: In addition, we demonstrate that NOX1, ADAM17, and membrane MCAM are present in a multiprotein complex in endothelial and cancer cells and that long-term treatment with NOX1 inhibitor partially decreases ADAM17 expression and the generation of sMCAM.